Stock Research for GWPRF

GWPRF

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

GWPRF Stock Chart & Research Data

The GWPRF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GWPRF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


GWPRF Due diligence Resources & Stock Charts

The GWPRF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View GWPRF Detailed Price Forecast - CNN Money CNN View GWPRF Detailed Summary - Google Finance
Yahoo View GWPRF Detailed Summary - Yahoo! Finance Zacks View GWPRF Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View GWPRF Trends & Analysis - Trade-Ideas Barrons View GWPRF Major Holders - Barrons
NASDAQ View GWPRF Call Transcripts - NASDAQ Seeking View GWPRF Breaking News & Analysis - Seeking Alpha
Spotlight View GWPRF Annual Report - CompanySpotlight.com OTC Report View GWPRF OTC Short Report - OTCShortReport.com
TradeKing View GWPRF Fundamentals - TradeKing Charts View GWPRF SEC Filings - Bar Chart
WSJ View Historical Prices for GWPRF - The WSJ Morningstar View Performance/Total Return for GWPRF - Morningstar
MarketWatch View the Analyst Estimates for GWPRF - MarketWatch CNBC View the Earnings History for GWPRF - CNBC
StockMarketWatch View the GWPRF Earnings - StockMarketWatch MacroAxis View GWPRF Buy or Sell Recommendations - MacroAxis
Bullish View the GWPRF Bullish Patterns - American Bulls Short Pains View GWPRF Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View GWPRF Stock Mentions - StockTwits PennyStocks View GWPRF Stock Mentions - PennyStockTweets
Twitter View GWPRF Stock Mentions - Twitter Invest Hub View GWPRF Investment Forum News - Investor Hub
Yahoo View GWPRF Stock Mentions - Yahoo! Message Board Seeking Alpha View GWPRF Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for GWPRF - SECform4.com Insider Cow View Insider Transactions for GWPRF - Insider Cow
CNBC View GWPRF Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for GWPRF - OTC Markets
Yahoo View Insider Transactions for GWPRF - Yahoo! Finance NASDAQ View Institutional Holdings for GWPRF - NASDAQ


Stock Charts

FinViz View GWPRF Stock Insight & Charts - FinViz.com StockCharts View GWPRF Investment Charts - StockCharts.com
BarChart View GWPRF Stock Overview & Charts - BarChart Trading View View GWPRF User Generated Charts - Trading View




Latest Financial News for GWPRF


This CBD Oil-Making Biotech Has Been Pummeled In 2019 — Here's Why
Posted on Monday October 14, 2019

Investors have pummeled GW stock recently, an analyst said, following recent concerns over prescriptions of its CBD oil, Epidiolex. Data suggest prescriptions slowed in early October.


Jim Cramer Gives His Opinion On Disney, Carnival Corp And More
Posted on Tuesday October 08, 2019

On CNBC's "Mad Money Lightning Round," Jim Cramer said he doesn't understand how New Relic Inc (NYSE: NEWR ) could have such a degradation. Leidos Holdings Inc (NYSE: LDOS ) is a winner and it ...


GW Pharmaceuticals: Target Price and Valuation Update
Posted on Monday October 07, 2019

Thirteen analysts are covering GW Pharmaceuticals in October. Nine covered the stock in October 2018. The consensus target price for the stock is $226.85.


GW Pharma Stock Has Plunged as Analyst Raises Questions Over Safety of Cannabis-Based Epilepsy Drug
Posted on Thursday October 03, 2019

Epidiolex was launched last November as the first cannabis medicine approved in the U.S. Shares of GW Pharmaceuticals have slumped, even though sales of the drug are soaring. The stock could go even lower.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.